Hjem › Kolesterol › North Carolina
Kliniske studier for Kolesterol i North Carolina
7 studier for Kolesterol søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Asheville Cardiology Associates Research Department, Asheville
- Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
- Mecklenburg Heart Specialists, Charlotte
- og 6 flere
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Duke Early Phase Clinical Research, Durham
- Peters Medical Research, High Point
RekruttererFase 1
Alder 18 til 75 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Durham
- Research Site, Morehead City
- Research Site, Statesville
- og 2 flere
RekruttererFase 3
Alder 18 til 130 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Monroe Biomedical Research, Monroe
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research - Durham, Durham
- Accellacare of Wilmington, Wilmington
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07477704Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Rekrutterer
Alder 40 til 75 · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 2
Alder 40 til 75 · Alle kjønn · Oppdatert 27. feb. 2026 · NCT06488105Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.